Načítá se...
Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease
BACKGROUND: Indoleamine 2,3 dioxygenase (IDO), the rate-limiting enzyme in the kynurenine (Kyn) pathway of tryptophan (Trp) degradation, is modulated by inflammation, and is regarded as a key molecule driving immunotolerance and immunosuppressive mechanisms. Little is known about IDO activity in pat...
Uloženo v:
| Vydáno v: | BMC Cardiovasc Disord |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8314527/ https://ncbi.nlm.nih.gov/pubmed/34311709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-021-02140-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|